Zinc-finger nucleases (ZFNs) are artificial restriction enzymes generated by fusing a zinc finger DNA-binding domain to a DNA-cleavage domain. Zinc finger domains can be engineered to target specific desired DNA sequences and this enables zinc-finger nucleases to target unique sequences within complex genomes. By taking advantage of endogenous DNA repair machinery, these reagents can be used to precisely alter the genomes of higher organisms. Alongside CRISPR/Cas9 and TALEN, ZFN is a prominent tool in the field of genome editing.

Market Analysis and Insights: Global Zinc Finger Nuclease Technology Market
The global Zinc Finger Nuclease Technology market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Zinc Finger Nuclease Technology market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Zinc Finger Nuclease Technology market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Zinc Finger Nuclease Technology market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Zinc Finger Nuclease Technology market.

Global Zinc Finger Nuclease Technology Scope and Market Size
Zinc Finger Nuclease Technology market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Zinc Finger Nuclease Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other

Segment by Application
Biotechnology Companies
Pharmaceutical Companies
Hospital Laboratory and Diagnostic Laboratory
Academic and Research Institutes
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Sigma-Aldrich
Sangamo Therapeutics
Labomics
Thermo Fisher Scientific
Gilead